Health Catalyst, Inc.
HCAT Healthcare Health Information Services
Health Catalyst, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $311.1 million, up 1.48% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS grew 6.78%, free cash flow grew 64.3% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow HCAT
Health Catalyst, Inc. (HCAT) EV/Sales
As of 16 October 2026, Health Catalyst, Inc. (HCAT) trades at a EV/Sales of 0.6×. Over the past ten years it has ranged from 0.0× (September 2019) to 12.5× (June 2021); the current reading is higher than 9% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.7× | (46.79%) |
| FY2024 | 1.4× | (6.26%) |
| FY2023 | 1.4× | (5.86%) |
| FY2022 | 1.5× | (77.06%) |
| FY2021 | 6.7× | (21.98%) |
| FY2020 | 8.6× | 181.33% |
| FY2019 | 3.1× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.7× | 49.29% |
| Mar 2026 | 0.5× | (37.38%) |
| Dec 2025 | 0.7× | (12.98%) |
| Sep 2025 | 0.8× | (17.59%) |
| 27 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation compare | 0.0× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| SY So-Young International Inc. Sponsored ADR compare | 0.5× |
| LFMD LifeMD, Inc. compare | 0.5× |
| HCAT Health Catalyst, Inc. | 0.6× |
| CCLD CareCloud, Inc. compare | 0.8× |
| SPOK Spok Holdings, Inc. compare | 1.5× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| CSLT Castlight Health, inc. compare | 1.9× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)